FR2377202A2 - Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone - Google Patents

Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone

Info

Publication number
FR2377202A2
FR2377202A2 FR7700706A FR7700706A FR2377202A2 FR 2377202 A2 FR2377202 A2 FR 2377202A2 FR 7700706 A FR7700706 A FR 7700706A FR 7700706 A FR7700706 A FR 7700706A FR 2377202 A2 FR2377202 A2 FR 2377202A2
Authority
FR
France
Prior art keywords
hexahydroxy
benzophenone
pharmaceutical compositions
compositions containing
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7700706A
Other languages
English (en)
Other versions
FR2377202B2 (fr
Inventor
Alain Rancurel
Georges Grenier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Pharmascience SA
Original Assignee
Laboratoires Pharmascience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Pharmascience SA filed Critical Laboratoires Pharmascience SA
Priority to FR7700706A priority Critical patent/FR2377202A2/fr
Priority to BE183753A priority patent/BE862197R/fr
Priority to JP121578A priority patent/JPS5388328A/ja
Priority to GB1250/78A priority patent/GB1548552A/en
Publication of FR2377202A2 publication Critical patent/FR2377202A2/fr
Application granted granted Critical
Publication of FR2377202B2 publication Critical patent/FR2377202B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic

Abstract

La présente invention concerne de nouvelles compositions pharmaceutiques. Il s'agit plus particulièrement d'une composition pharmaceutique pour le traitement des déficits fonctionnels et des perturbations métaboliques qui découlent d'une insuffisance circulatoire cérébrale et/ou periphérique qui contient à titre de principe actif l'hexahydroxy-2,3,4,3',4',5-benzophénone. Ces compositions sont utiles notamment pour le traitement des oedèmes cérébraux.
FR7700706A 1977-01-12 1977-01-12 Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone Granted FR2377202A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7700706A FR2377202A2 (fr) 1977-01-12 1977-01-12 Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone
BE183753A BE862197R (fr) 1977-01-12 1977-12-22 Derives biphenyles utiles comme medicaments
JP121578A JPS5388328A (en) 1977-01-12 1978-01-11 Chemicals containing 2*3*4*3**4**5** hexahydroxybenzophenone
GB1250/78A GB1548552A (en) 1977-01-12 1978-01-12 Process for preparing 2,3,3'-4,4,5'-hexahydroxybenzophenonand pharmaceutical compositions containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7700706A FR2377202A2 (fr) 1977-01-12 1977-01-12 Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone

Publications (2)

Publication Number Publication Date
FR2377202A2 true FR2377202A2 (fr) 1978-08-11
FR2377202B2 FR2377202B2 (fr) 1979-04-20

Family

ID=9185386

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7700706A Granted FR2377202A2 (fr) 1977-01-12 1977-01-12 Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone

Country Status (4)

Country Link
JP (1) JPS5388328A (fr)
BE (1) BE862197R (fr)
FR (1) FR2377202A2 (fr)
GB (1) GB1548552A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315964A1 (fr) * 1987-11-11 1989-05-17 Laboratoires Pharmascience Composition pharmaceutique comprenant l'exifone et un polymère soluble dans l'eau
FR2714381A1 (fr) * 1993-12-29 1995-06-30 Pharmascience Lab Dérivés de la benzoxazine, leurs procédés d'obtention et leur utilisation en tant que médicaments .

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02206A (ja) * 1987-11-11 1990-01-05 Fujisawa Pharmaceut Co Ltd エキシホンと水溶性高分子化合物とを含有することを特徴とする新規製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257272B1 (fr) * 1974-01-15 1978-08-25 Pharmascience Labo
GB1549171A (en) * 1975-04-17 1979-08-01 Lilly Industries Ltd Pharmaceutical formulations containing hydrocy bezophenonederivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315964A1 (fr) * 1987-11-11 1989-05-17 Laboratoires Pharmascience Composition pharmaceutique comprenant l'exifone et un polymère soluble dans l'eau
FR2714381A1 (fr) * 1993-12-29 1995-06-30 Pharmascience Lab Dérivés de la benzoxazine, leurs procédés d'obtention et leur utilisation en tant que médicaments .
WO1995018114A1 (fr) * 1993-12-29 1995-07-06 Laboratoires Pharmascience Derives de la benzoxazine, leurs procedes d'obtention et leur utilisation en tant que medicaments
US5804580A (en) * 1993-12-29 1998-09-08 Laboratories Pharmascience Benzoxazine derivatives, methods for obtaining same, and their use as drugs

Also Published As

Publication number Publication date
JPS6319498B2 (fr) 1988-04-22
GB1548552A (en) 1979-07-18
FR2377202B2 (fr) 1979-04-20
JPS5388328A (en) 1978-08-03
BE862197R (fr) 1978-06-22

Similar Documents

Publication Publication Date Title
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2421615A1 (fr) Methode de traitement de l'acne et compositions pharmaceutiques contenant de l'acide salicylique et du peroxyde de benzoyle convenant a cette fin
MA24729A1 (fr) Macrolides nouveaux.
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99006A1 (fr) 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN96172A1 (fr) Composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26697A1 (fr) Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
MA27121A1 (fr) Derives 2-(purin-9-yl)-tetrahydrofuran-3,4-diol
FR2445146A1 (fr) Medicament a prise orale contenant une substance inhibitrice de l'inflammation et un ou plusieurs phospholipides
TNSN96085A1 (fr) Amides therapeutiques et compositions les contenant
MA26723A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
FI954131A (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
FR2415112A1 (fr) Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
BE905890A (fr) Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa.
TNSN98210A1 (fr) Trifluoromethylethers cycliques a fonction piperidinylaminomethyle, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2608045B1 (fr) Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
NO942610D0 (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
TNSN98185A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
FR2377202A2 (fr) Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees
BE900178A (fr) Urees et thio-urees anti-atherosclerotiques.